Medicenna to present at H.C. Wainwright 28th annual global conference
Medicenna Therapeutics Corp. announced it will present at the H.C. Wainwright 28th Annual Global Investment Conference.
TORONTO and HOUSTON, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases, announced today tha…